Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Conatus raises $66 million in IPO

July 26, 2013 1:23 AM UTC

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) was off $1.50 (14%) to $9.50 in its first day of trading on Thursday after raising $66 million through the sale of 6 million shares at $11 in a bumped-up IPO. The $11 price valued the company at $171.3 million. Earlier this month, Conatus said it planned to sell 5 million shares at $10-$12. Stifel; Piper Jaffray; JMP Securities; and SunTrust are underwriters. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article